Procalcitonin measurement in west nile virus neuroinvasive disease: A first case series

0Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

West Nile virus neuroinvasive disease (WNV-NID) is challenging to diagnose. Procalcitonin (PCT) is a useful diagnostic test to iden-tify bacterial infections. We present four cases of WNV-NID with serum PCT measurements. METHODS: Daily (days 1–7) serum PCT (bioMérieux) was examined for critically ill patients with sepsis enrolled in a provincial sepsis study. Patients with identified WNV-NID are descriptively analyzed in this case series. PCT values of ≥0.5 ng/mL were suggestive of bacterial infection. RESULTS: Four patients with WNV-NID were identified. Those with viral infections alone had consistently low PCT values ranging from 0.09 ng/mL to 0.34 ng/mL. Those with documented bacterial co-infections had initially elevated PCT levels that decreased by more than 50% with antimicrobial therapy. CONCLUSION: These cases are the first to report serial PCT measurements in confirmed cases of WNV-NID and support a low serum PCT in WNV-NID.

Cite

CITATION STYLE

APA

Boehm, C., Doig, C., Chen, J. Z., Sligl, W. I., Bagshaw, S. M., & Conly, J. (2021). Procalcitonin measurement in west nile virus neuroinvasive disease: A first case series. Journal of the Association of Medical Microbiology and Infectious Disease Canada, 6(3), 229–235. https://doi.org/10.3138/JAMMI-2020-0046

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free